| 摘要 |
<p>Stable formulations of PTH that may be administered to animal or human subjects are provided herein. In one embodiment, the PTH formulations described herein is in the form of a stable solution formulation comprising PTH, methionine, at least one Poloxamer surfactant, and a physiologically acceptable buffering agent. Also described herein are methods of making and using the PTH formulations described herein.</p> |
